Stock & Company Details
Cocrystal Pharma Inc $COCP
Price:
N/A
N/A
19M
$22M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.56
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
COCP technical indicators
Latest Cocrystal Pharma Inc (COCP) indicator readings as of 2026-09-18.
COCP's 14-day RSI is 59.2, in neutral territory. At $1.21 it is trading 10.3% above its 200-day moving average of $1.10, and above its 50-day average of $1.06. Price sits near the upper Bollinger Band ($1.07 to $1.24). ADX reads 19.7, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
Finance Bot
Ask your questions
Start by typing a question below.
